Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
P/E ratio for Science 37 Holdings, Inc. (SNCE)
P/E ratio as of 2022: -18.87
According to Science 37 Holdings, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -18.87. At the end of 2021 the company had a P/E ratio of -0.09.
P/E ratio history for Science 37 Holdings, Inc. from 2019 to 2022
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2022 | -18.87 |
| 2021 | -0.09 |
| 2020 | -91.87 |
| 2019 | -110399.90 |